Press Releases

GlobeNewswire, Inc.

Delray Beach, FL, March 30, 2026 (GLOBE NEWSWIRE) -- The global dental laboratories market, valued at US$8.66 billion in 2024, stood at US$9.20 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating...

GlobeNewswire, Inc.

Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United...

GlobeNewswire, Inc.

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...

GlobeNewswire, Inc.

BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...

GlobeNewswire, Inc.

TORONTO and VADUZ, Liechtenstein, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner...

Organization for Security and Co-operation in Europe

From 14 to 17 November, the OSCE Secretariat, in partnership with the OSCE Academy in Bishkek, gathered 26 young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions for a dynamic four-day seminar in...

EIN Presswire

How the LBA is balancing tradition, transparency, and technology to shape the future of Liechtenstein’s financial centre LONDON, UNITED KINGDOM, July 7, 2025 /⁨EINPresswire.com⁩/ -- Simon Tribelhorn, CEO of the Liechtenstein Bankers Association...

GlobeNewswire, Inc.

Geneva, Switzerland / India, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products,,...

GlobeNewswire, Inc.

First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...

EIN Presswire

The Business Research Company's Coatings And Application Technologies For Robotics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 2, 2025 /⁨EINPresswire.com⁩/ -- "Get 30%...

EIN Presswire

Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /⁨EINPresswire.com⁩/ -- Virella Ltd, a European biotech...

GlobeNewswire, Inc.

LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, through a unified...

GlobeNewswire, Inc.

New York, April 24, 2026 (GLOBE NEWSWIRE) -- Youth Power Ventures (YPV) is pleased to announce the appointment of Ambassador Hana Ibrahimova to its senior management team.

GlobeNewswire, Inc.

New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...

GlobeNewswire, Inc.

Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.

GlobeNewswire, Inc.

If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...

GlobeNewswire, Inc.

New LEO constellation represents major step for UK and European space industry Empowers nations and partners with resilient, real-time intelligence and protected space-based connectivity BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) -- Open...

GlobeNewswire, Inc.

Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...

EIN Presswire

Obyte community members can now make 1% a day by making friends every day and spreading the word about Obyte's unstoppable, censorship-resistant tech TRIESEN, LIECHTENSTEIN, January 2, 2026 /⁨EINPresswire.com⁩/ -- Obyte, the DAG-based...

GlobeNewswire, Inc.

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the EU, will distribute following expected...